|Bid||31.00 x 1000|
|Ask||43.00 x 1400|
|Day's Range||39.51 - 41.51|
|52 Week Range||25.09 - 54.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||210.87|
|Earnings Date||Mar 23, 2022 - Mar 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||57.43|
It might be of some concern to shareholders to see the Harmony Biosciences Holdings, Inc. ( NASDAQ:HRMY ) share price...
At this time, I would like to welcome everyone to the Harmony Biosciences first quarter 2022 financial update conference call. Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences' first quarter 2022 financial performance and provide a business update.
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 104% and 2.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?